Dr Mark Davies brings over 20 years’ experience in drug development, both from the perspective of working within major pharmaceutical companies (such as AstraZeneca); but also in providing services into biopharma companies worldwide. During this time, his roles have spanned a variety of different disease areas and different phases of drug discovery and development.
His main areas of experience are within computational biology and data informatics bringing a collaborative approach to improve how we work with and analyse datasets from different sources. He has numerous peer-reviewed publications and broad experience in experimental techniques, informatics and their applications to modelling so to answer critical questions in drug discovery.
More recently, he has worked in business development roles for state-funded (Medicines Discovery Catapult) and multiple CRO organisations across Europe , bringing a consultative approach to the utility of informatics-based approaches to questions in the healthtech and pharmaceutical industry.
Mark has a PhD in Biological Sciences, from the University of Warwick, UK, and B.Sc in Biochemistry from University of Bath, UK.
Interested in speaking with a consultant?
We’ll arrange a brief consultation for you with a specialist in our team.
